The Pennant Group, Inc. (NASDAQ:PNTG) Stake Cut by Crewe Advisors LLC

Crewe Advisors LLC lowered its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 97.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,750 shares of the company's stock after selling 726,208 shares during the period. Crewe Advisors LLC's holdings in The Pennant Group were worth $444,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Quarry LP boosted its stake in shares of The Pennant Group by 371.6% during the 3rd quarter. Quarry LP now owns 1,014 shares of the company's stock valued at $36,000 after buying an additional 799 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. raised its stake in shares of The Pennant Group by 460.2% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,311 shares of the company's stock valued at $118,000 after purchasing an additional 2,720 shares in the last quarter. USA Financial Formulas acquired a new position in The Pennant Group in the third quarter worth about $121,000. Intech Investment Management LLC bought a new stake in The Pennant Group in the third quarter valued at about $232,000. Finally, Summit Global Investments bought a new position in The Pennant Group during the 3rd quarter worth approximately $254,000. 85.88% of the stock is owned by institutional investors and hedge funds.

The Pennant Group Price Performance

PNTG stock traded down $0.56 during trading on Friday, hitting $26.66. The company had a trading volume of 95,105 shares, compared to its average volume of 205,807. The firm has a market capitalization of $915.72 million, a price-to-earnings ratio of 39.14, a P/E/G ratio of 2.35 and a beta of 1.91. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.58. The business has a 50 day moving average of $27.82 and a 200 day moving average of $30.92. The Pennant Group, Inc. has a fifty-two week low of $15.01 and a fifty-two week high of $37.13.

Analyst Upgrades and Downgrades

PNTG has been the topic of several research analyst reports. Oppenheimer raised their price objective on The Pennant Group from $34.00 to $37.00 and gave the stock an "outperform" rating in a research note on Friday, November 8th. Truist Financial cut their target price on shares of The Pennant Group from $38.00 to $32.00 and set a "hold" rating on the stock in a report on Monday, January 6th. Royal Bank of Canada raised their price target on The Pennant Group from $26.00 to $38.00 and gave the stock an "outperform" rating in a report on Wednesday, October 23rd. Finally, Wells Fargo & Company started coverage on shares of The Pennant Group in a report on Thursday, December 19th. They set an "equal weight" rating and a $33.00 price target for the company. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $36.00.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.